Researchers at Harvard University’s Wyss Institute for Biologically Inspired Engineering have discovered a potential ...

据哈佛大学Wyss生物启发工程研究所的研究人员称，FDA批准的治疗阿尔茨海默氏症的药物多奈哌齐（Donepezil）有可能被重新用于紧急情况，以防止不可逆的器官损伤。 “长期以来，医疗机构一直使用冷却病人的身体以减缓其代谢过程，以减少严重情况下的伤害和长期问题，但目前只能在资源充足的医院完成，”Wyss研究所免疫材料主任，合著者Michael ...

The research team’s innovative approach resulted in a series of novel molecules that show high effectiveness as dual ...

There are four dementia-specific medications approved in Australia – donepezil, galantamine, rivastigmine, and memantine.

Earlier this year Nice decided not to fund the new ‘miracle’ Alzheimer’s drug on the NHS, but who makes that decision?

Scientists from Agharkar Research Institute, Pune, an autonomous institute of Department of Science and Technology, ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

Scientists have designed and synthesized novel molecules through a blend of synthetic, computational, ...

Researchers use real-world data in the United States to evaluate the protective role of semaglutide against Alzherimer’s ...

However, given the upcoming patent expirations (rivastigmine going off-patent in 2007, galantamine in 2008, donepezil and memantine in 2010) and the likely entry of generics, the total value of ...

Climate change could drive up demand for drugs to treat asthma, kidney disease and Alzheimer's and add to supply chain ...

RAND focused its model on four chronic conditions — cardiovascular disease, asthma, end-stage kidney disease and Alzheimer’s ...